Cure SMA Breaking News
no more sma angels
Three FDA-approved treatments are changing the course of SMA.
August 2020 - FDA APPROVES evrysdi
Genentech receives FDA approval of Evrysdi, an oral medication, for spinal muscular atrophy for adult patients and children two+ months.
MAY 2019 - FDA APPROVES ZOLGENSMA
AveXis receives FDA approval of Zolgensma, a gene therapy, for spinal muscular atrophy for patients under two years of age.
DECEMBER 2016 - FDA APPROVES SPINRAZA
Biogen receives FDA approval of Spinraza, making it the first-ever treatment for all patients with spinal muscular atrophy.